**AI生物科学初创公司Bioptimus获3500万美元种子轮融资**
法国人工智能新星Bioptimus在生物科学领域迈出了重大的一步，宣布成功完成3500万美元的种子轮融资。这家初创公司旨在利用人工智能技术为生物技术构建一个强大的语言模型，以推动该领域的创新和研究。Bioptimus在成立不久后便吸引了众多投资者的目光，彰显了其在AI生物科学领域的巨大潜力。
本轮融资由法国知名生命科学风险投资公司Sofinnova Partners和公共银行Bpifrance Large Ventures共同领投，显示出业界对Bioptimus技术前景的强烈信心。此外，法国风险投资公司Frst、全球投资公司Cathay Innovation、硅谷风投Headline，以及知名亿万富翁企业家Xavier Niel也纷纷加入投资阵容，为Bioptimus的发展注入了更多动力。
Bioptimus的这一轮融资不仅为公司的技术研发提供了资金保障，同时也标志着AI与生物科学融合的新兴趋势正在加速发展。随着这些资金的到位，Bioptimus有望加速其语言模型的构建，为生物技术行业带来革命性的变化，进一步推动医疗健康、药物研发等领域的科技进步。
此次融资事件也凸显了法国作为创新和技术孵化中心的地位，以及全球投资者对人工智能和生物科技交叉领域初创企业的浓厚兴趣。Bioptimus的未来表现值得期待，它可能会成为AI生物科学领域的一颗璀璨新星。
英语如下：
**AI Biotech Startup Bioptimus Raises $35 Million Seed Funding to Develop AI Language Model for Biosciences**
Keywords: Bioptimus, seed round, $35 million
News Content:
French AI newcomer Bioptimus has taken a significant stride in the biosciences sector, announcing the successful completion of a $35 million seed funding round. The startup aims to leverage artificial intelligence technology to create a powerful language model for biotechnology, fostering innovation and research in the field. Bioptimus has quickly captured the attention of investors, demonstrating its substantial potential in AI-driven biosciences.
The seed round was jointly led by prominent life science venture capital firm Sofinnova Partners and public bank Bpifrance Large Ventures, indicating strong confidence in Bioptimus’s technological prospects. Other investors participating in the round include French venture capital firm Frst, global investment firm Cathay Innovation, Silicon Valley-based venture capital firm Headline, and billionaire entrepreneur Xavier Niel, adding further momentum to Bioptimus’s growth.
This funding not only secures resources for the company’s R&D but also underscores the accelerating trend of AI integration in biosciences. With the influx of capital, Bioptimus is poised to expedite the development of its language model, potentially revolutionizing the biotech industry and driving advancements in healthcare and drug discovery.
The financing round underscores France’s position as a hub for innovation and tech incubation and reflects the global investor interest in AI-driven startups at the intersection of biotechnology. Bioptimus’s future performance is eagerly awaited, as it has the potential to emerge as a shining star in the AI biosciences landscape.
【来源】https://sifted.eu/articles/bioptimus-owkin-35m-seed
Views: 2